Literature DB >> 9233663

Is human granulocytic ehrlichiosis a new Lyme disease? Review and comparison of clinical, laboratory, epidemiological, and some biological features.

J S Dumler1.   

Abstract

Human granulocytic ehrlichiosis (HGE) and Lyme disease are caused by infectious agents transmitted by deer ticks (Ixodes scapularis). Because of the shared tick vector and increased seroprevalence of HGE in patients with Lyme disease, there is some confusion about the identity of these infectious agents and the clinicopathologic spectrum of the disease. HGE is an acute febrile illness associated with leukopenia, thrombocytopenia, and increased serum activities of hepatic transaminases. In contrast, Lyme disease is most often subacute, with the frequent presence of erythema migrans rash and infrequent leukopenia, thrombocytopenia, or elevated serum hepatic transaminase activities. Some ehrlichia infections in animals and humans may become persistent, and Ehrlichia-mediated defects in host defense and immune suppression can allow secondary and opportunistic infections. Because of these properties of Ehrlichia species, their role in modifying the clinical course of Lyme disease may be hypothesized and should be tested.

Entities:  

Mesh:

Year:  1997        PMID: 9233663     DOI: 10.1086/516164

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

1.  Human granulocytic ehrlichiosis agent infection in a pony vaccinated with a Borrelia burgdorferi recombinant OspA vaccine and challenged by exposure to naturally infected ticks.

Authors:  Y F Chang; S P McDonough; C F Chang; K S Shin; W Yen; T Divers
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

2.  Coinfection with Anaplasma phagocytophilum alters Borrelia burgdorferi population distribution in C3H/HeN mice.

Authors:  Kevin Holden; Emir Hodzic; Sunlian Feng; Kimberly J Freet; Rance B Lefebvre; Stephen W Barthold
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

3.  Reassessment of a midwestern Lyme disease focus for Borrelia burgdorferi and the human granulocytic ehrlichiosis agent.

Authors:  Craig A Jackson; Steven D Lovrich; William A Agger; Steven M Callister
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

4.  Evaluation of antibiotic susceptibilities of Ehrlichia canis, Ehrlichia chaffeensis, and Anaplasma phagocytophilum by real-time PCR.

Authors:  S Branger; J M Rolain; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

5.  Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States.

Authors:  Max Maurin; Johan S Bakken; J Stephen Dumler
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

6.  Cytoplasmic, nuclear, and platelet autoantibodies in human granulocytic ehrlichiosis patients.

Authors:  S J Wong; J A Thomas
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.